When is the deadline for the National Institutes of Health RFP?

The deadline for this RFP is Jul 17, 2026. Make sure to submit your proposal before this date to be considered.

How do I find RFPs before my competitors?

Starbridge centralizes thousands of state, local, education, and university bid portals into one AI-powered feed. We monitor 24/7 and alert you the moment an RFP drops, so you're always first to know. Plus, we track early buying signals—like contract expirations and meeting minutes—months before RFPs are released.

Should I wait for the RFP to be released?

No. If you're not already part of the RFP writing process, you're already behind. Starbridge helps you identify opportunities months early through buying signals like strategic plans, board meeting mentions, contract expirations, and new budgets—so you can influence requirements before competitors even see the RFP.

How does Starbridge help me win more RFPs?

Starbridge helps you create winning proposals in half the time with AI-powered proposal drafting based on your product knowledge base. We auto-fill responses, generate compliance matrices, and provide real-time collaboration tools. Plus, you get verified decision-maker contacts and account intelligence to tailor your approach.

What results do Starbridge customers see?

Starbridge customers report booking 5 meetings in their first week, 40% lifts in campaign response rates, and identifying 300+ opportunities in their first month. On average, Starbridge helps sales teams book 30-40% of leads into meetings by targeting the right accounts at the right time.

G-Rex500M Bioreactors for Cell Therapy Manufacturing

RFPs/...

Retrieving RFP details

Summary

What to Include In Your Proposal

Starbridge can help you:

Pain points mentioned in board meetings and strategic plans

Instantly outline and draft all requirements

Bring in your USPs and exploit competitor gaps

Win These Opportunities Next

Starbridge can help you:

Get ahead of RFPs — target accounts planning budget or ending contracts soon

Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more

Starbridge.ai books 30 - 40% of leads into meetings

Files

Contacts & Company Data

Premium

Verified names, emails & phone numbers

AI-predicted best buyers in the org

Auto-sync to Salesforce & HubSpot

Access the largest public sector contact database

Competitor Intelligence

Premium

See which competitors are likely to bid

Line-item pricing breakdowns

Contract expiration map of your TAM

Get complete source documentation & analysis

More Opportunities Like This

G-Rex500M Bioreactors for Cell Therapy Manufacturing RFP

Available

National Institutes of Health

The National Institutes of Health (NIH) Clinical Center, Office of Acquisitions and Logistics Management (OALM) issued a Notice of Intent to Award a Sole Source Contract for the procurement of seven cases of G-Rex500M-CS bioreactors from Wilson Wolf Manufacturing LLC. These bioreactors support manufacture of cell-based therapies for patients enrolled in NIH clinical trials at the NIH Clinical Center. The acquisition is being conducted under FAR 13.106-1(b)(1) – Soliciting from a Single Source, since Wilson Wolf is the only known source capable of providing the validated G-Rex500M bioreactors required for FDA-regulated manufacturing.

Posted Date

Jul 8, 2026

Due Date

Jul 17, 2026

View Details →

G-Rex500M Bioreactors for Cell Therapy Manufacturing RFP

Release: Jul 8, 2026

National Institutes of Health

Close: Jul 17, 2026

Available

View Details →

Study of Cell and Gene Therapy Research, Manufacturing, and Delivery

Available

Minnesota Department of Health

A feasibility study is requested to assess Minnesota's current capacity for rare-disease cell and gene therapy across research, innovation, commercialization, biomanufacturing, and delivery, and to provide a strategic gap analysis with recommendations for national leadership positioning. The solicitation appears linked to state legislative direction for the commissioner of health to conduct a comprehensive study on cell and gene therapies for rare diseases and to submit a report (statute directs MDH to produce findings and recommendations by January 1, 2028). The BidNet listing shows the solicitation published 2026-06-26 and closing 2026-07-24, and the original buyer-hosted procurement page or a solicitation PDF was not found in the reviewed corpus.

Posted Date

Jun 26, 2026

Due Date

Jul 24, 2026

View Details →

Study of Cell and Gene Therapy Research, Manufacturing, and Delivery

Release: Jun 26, 2026

Minnesota Department of Health

Close: Jul 24, 2026

OPC UA / LADS Platform-Agnostic, Software for Monitoring and Control of Bioreactors (RFP)

Available

University of Delaware

Provide creation of platform-agnostic software compliant with OPC UA and companion specifications to enable machine-to-machine communication for most commercially available bioreactor systems with orchestrating systems and supporting devices to conduct and monitor automated mammalian cell culture. The developed software will additionally support higher levels of interoperability through alignment with Industrial Ontologies Foundry (IOF) and Allotrope semantic standards. The developed software will be demonstrated, documented, and delivered to the Big-Data Program / Data Structure and Management Workstream within NIIMBL.

Posted Date

Due Date

Jul 31, 2026

View Details →